Core Wealth Advisors, Inc. Amgen Inc Transaction History

Core Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $13,807 - $15,576	54 New	54 $15,000
Q2 2020 Jul 31, 2020	SELL	$197.81 - $242.74 $2,373 - $2,912	-12 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $1,093 - $1,450	6 Added 100.0%	12 $2,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $1,135 - $1,459	6 New	6 $1,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Core Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Core Wealth Advisors, Inc. with notifications on news.